Top compounds associated with response to EIF3K

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	paclitaxel	CCLE	pan-cancer	AAC	0.12	0.009
mRNA	Parthenolide	CTRPv2	pan-cancer	AAC	-0.1	0.01
mRNA	sirolimus:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.085	0.01
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.091	0.01
mRNA	AZD0530	CCLE	pan-cancer	AAC	0.12	0.01
mRNA	Y-39983	GDSC1000	pan-cancer	AAC	-0.079	0.01
mRNA	MK-2206	GDSC1000	pan-cancer	AAC	0.088	0.02
mRNA	navitoclax:MST-312 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.086	0.02
mRNA	prochlorperazine	CTRPv2	pan-cancer	AAC	-0.09	0.02
mRNA	SNX-2112:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.077	0.02

Download CSV